TheReadout

AstraZeneca's Bold Bet: Charging Hard into China's Obesity Drug Race and Beyond

Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

The Evolving Landscape of Biotech Innovation and Investment

Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets

Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care

Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

Trump's Landmark Drug Price Promise: A Deadline Vanished, Unnoticed